Lionel Adès

59PUBLICATIONS
376CO-AUTHORS
Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Molecular targetsCardiovascular medicine and haematology not elsewhere classifiedRegenerative medicine (incl. stem cells)Predictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (59)

|Aug 26, 2026
Ivosidenib monotherapy in IDH1 mutated myelodysplastic neoplasm/syndrome.

|Jul 08, 2026
Splicing-associated network PAK1-CLK1/4-SRRM1 is a vulnerability to overcome chemoresistance in human and mouse acute myeloid leukemia.

|Mar 10, 2026
Does stringent cytoreduction improve survival in advanced proliferative chronic myelomonocytic leukemia?

Dorothée Selimoglu-Buet, Sylvie Chevret, Valeria Santini

|Oct 08, 2025
Transplantation in patients with lower-risk MDS: a prospective phase 2 trial based on donor availability.

Marie Sébert, Sylvain Thepot, Thomas Cluzeau

|Sep 09, 2025
Allogeneic hematopoietic stem cell transplantation in patients with germ line DDX41 mutated myeloid malignancies.

Michael Loschi, Marie-Charlotte Villy, Jacques-Emmanuel Galimard

|Jun 25, 2025
IPSS-M risk and specific sex-associated somatic mutations predict response to ESA therapy in LR-MDS: building a new score.

Marco G Raddi, Sophie Park, Michaela Fontenay

Pageof 10

Frequent Collaborators

21 joint publications

Raphaël Itzykson

13 joint publications

Lin-Pierre Zhao

12 joint publications

Nicolas Duployez

12 joint publications

Uwe Platzbecker